Last updated on February 2019

An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma


Brief description of study

Asthma is a chronic inflammatory disease of airways and lungs that results in hyper-reactivity and clinically relevant episodes of wheezing. This study has been designed to assess the correct use and ease of use of the ELLIPTA DPI in pediatric subjects with asthma. ELLIPTA DPI is easy to use, requires few steps, is consistent in dosing and eliminates the hand-breath co-ordination required for metered dose inhalers (MDIs). Subjects will be stratified by age into two strata: Stratum 1: subjects in the age group of 5 to 7 years and Stratum 2: Subjects in the age group of 8 to 11 years. All subjects will be trained by Health care professionals (HCP) for the correct use of ELLIPTA DPI. Subjects will be given three chances to attempt correct use of ELLIPTA DPI; subsequently, if the subject is not successful, the parent/guardian will be able to help instruct the subject on the correct use of the ELLIPTA DPI. The subjects who will be enrolled in the study will take placebo ELLIPTA DPI once daily. After 28 days subjects will be randomized in 1:1 to receive a questionnaire (Version A and B). After completion of the questionnaire on ELLIPTA DPI ease of use, subject's ability to use ELLIPTA DPI correctly will be re-assessed. Approximately 219 subjects will be screened to participate in the study. The study will be conducted for 28 days. ELLIPTA is a registered trademark of GlaxoSmithKline (GSK) group of companies.

Clinical Study Identifier: NCT03478657

Contact Investigators or Research Sites near you

Start Over

US GSK Clinical Trials Call ...

GSK Investigational Site
Brampton, ON Canada

US GSK Clinical Trials Call ...

GSK Investigational Site
Burlington, ON Canada

US GSK Clinical Trials Call ...

GSK Investigational Site
London, ON Canada

US GSK Clinical Trials Call ...

GSK Investigational Site
Windsor, ON Canada

US GSK Clinical Trials Call ...

GSK Investigational Site
Owensboro, KY United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Columbus, OH United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Little Rock, AR United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Aventura, FL United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Miami, FL United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Plantation, FL United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Minneapolis, MN United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Plymouth, MN United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Columbia, MO United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Dayton, OH United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Summerville, SC United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Austin, TX United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Waco, TX United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Huntington Beach, CA United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Napa, CA United States

US GSK Clinical Trials Call ...

GSK Investigational Site
South Bend, IN United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Rolla, MO United States

US GSK Clinical Trials Call ...

GSK Investigational Site
Asheville, NC United States

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.